Approval · Notice of Compliance 14968 · 2013
AZASITE: Notice of Compliance 14968
Issued November 20, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14968
- Date
- November 20, 2013
- Company
- Inspire Pharmaceuticals IncLake Forest, Illinois, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product and change in the storage recommendation for the sample size product
- Therapeutic class
- Macrolide antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZASITE | Not yet assigned | — |
Medicinal ingredients
- AZITHROMYCIN 10 MG per ML